LUCD News and Press, Lucid Diagnostics Inc.

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 PR Newswire Conference Call and Webcast at 8:30AM Eastern Time NEW YORK , May 2, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or...

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing PR Newswire EsoGuard demonstrated unprecedented early precancer de...

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month PR Newswire NEW YORK , April 29, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commer...

2024-04-19 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Let’s just get something straight off the bat – penny stocks to rebound are risky. They’re incredibly treacherous in terms of both short-term downside and longer-term d...

2024-04-08 09:00:06 ET Mark Massaro from BTIG issued a price target of $2.50 for LUCD on 2024-04-08 07:51:00. The adjusted price target was set to $2.50. At the time of the announcement, LUCD was trading at $0.9277. The overall price target consensus is at $3.30 with hig...

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference PR Newswire NEW YORK , April 8, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention...

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results PR Newswire Lucid's quarterly revenue increased 33 percent sequentially Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio tec...

2024-03-26 16:27:08 ET Lucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Conference Call March 26, 2024, 08:30 AM ET Company Participants Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Kyle Mikson - Canaccord Joseph Con...

2024-03-25 17:55:53 ET Read the full article on Seeking Alpha For further details see: Lucid Diagnostics reports preliminary Q4 results

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results PR Newswire Quarterly EsoGuard ® revenue increased 33 percent sequentially Expanding EsoGuard clinical validity and clinical utility data poised to d...